Research, Science and Treatments

EPHB2 as a New Treatment Target for Mesothelioma

Last week, the Journal of Thoracic Oncology published the results of a study looking into the overexpression of the ephrin B2 receptor (EPHB2) in patients with mesothelioma. The researchers at the New York University Langone Medical Center observed that EPHB2 is overexpressed in all malignant mesothelioma cell lines, but not in benign mesothelial cells. In addition, […]




Genetics and the BAP1 Gene in Mesothelioma

BAP1 is the first gene discovered in mesothelioma. Not everyone has the mutated copy of this gene and, in fact, we are just embarking on trials to try to get a better handle on the incidence.
In germ line mutations (inherited mutation), the gene is thought to be extremely rare but has some interesting associations with […]


Complementary Cancer Therapies: Helpful or Hurtful?

Every year, consumers spend an estimated $40 billion on complementary and alternative medicine treatments and products, with hopes of miraculous cures, often unsupported by research or by science. Some consumers affected by life-threatening illnesses, including cancer, may approach the topic of supplements or alternative therapies as an added bonus without considering the side-effects or the […]